Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Original BioMedicals Co., Ltd. (6483.TWO)

12.40
+0.35
+(2.90%)
At close: 2:59:39 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
--
--
43
107
Cost of Revenue
--
--
8
12
Gross Profit
--
--
35
95
Operating Expense
78,331
78,331
59,297
40,271
Operating Income
-78,331
-78,331
-59,262
-40,176
Net Non Operating Interest Income Expense
3,320
3,320
-397
-726
Pretax Income
-74,998
-74,998
-59,661
-40,277
Net Income Common Stockholders
-74,998
-74,998
-59,661
-40,277
Diluted NI Available to Com Stockholders
-74,998
-74,998
-59,661
-40,277
Basic EPS
-1.14
--
-1.21
-0.86
Diluted EPS
-1.14
--
-1.21
-0.86
Basic Average Shares
65,787.72
--
49,306.61
46,833.72
Diluted Average Shares
65,787.72
--
49,306.61
46,833.72
Total Expenses
78,331
78,331
59,305
40,283
Net Income from Continuing & Discontinued Operation
-74,998
-74,998
-59,661
-40,277
Normalized Income
-74,998
-74,998
-59,661
-40,277
Interest Income
4,188
4,188
701
470
Interest Expense
868
868
1,098
1,196
Net Interest Income
3,320
3,320
-397
-726
EBIT
-74,130
-74,130
-58,563
-39,081
EBITDA
-65,729
-65,729
-49,826
-31,143
Reconciled Cost of Revenue
--
--
8
12
Reconciled Depreciation
8,401
8,401
8,737
7,938
Net Income from Continuing Operation Net Minority Interest
-74,998
-74,998
-59,661
-40,277
Normalized EBITDA
-65,729
-65,729
-49,826
-31,143
12/31/2022 - 3/27/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers